Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose decitabine plus aclacinomycin/cytarabine for refractory or relapsed acute myeloid leukemia
ChiCTR-TNC-12001999Phase 4Completed
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of decitabine, aclarubicin and cytarabine in acute myeloid leukemia (AML), sponsored by Shanghai Sixth People's Hospital. Primary endpoint: Complete remission rate. Started Aug 2008; status: completed.
02
Drugs
decitabineaclarubicincytarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on ChiCTR-TNC-12001999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNC-12001999.